Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Core LaboratoriesCLB -0.44%62 Cash-to-Debt is 0.14 as of Jun. 2026, which is 100% above its 10-year median of 0.07. GuruFocus rates CLB with a GF Score™ of 62/100 and a GF Value™ of $16.97 (Significantly Undervalued). The stock has 3 warning signs investors should review. Among 990 Oil & Gas companies, Core Laboratories ranks worse than 76.97% on this metric.
Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Core Laboratories's cash to debt ratio for the quarter that ended in Jun. 2026 was 0.14.
If Cash to Debt ratio is less than 1, the company cannot pay off its debt using the cash in hand. Here we can see, Core Laboratoriescouldn't pay off its debt using the cash in hand for the quarter that ended in Jun. 2026.
The historical rank and industry rank for Core Laboratories's Cash-to-Debt or its related term are showing as below:
CLB'
s Cash-to-Debt Range Over the Past 10 Years
Min: 0.03 Med: 0.07 Max: 0.18
Current: 0.14
During the past 13 years, Core Laboratories's highest Cash to Debt Ratio was 0.18. The lowest was 0.03. And the median was 0.07.
CLB's Cash-to-Debt is ranked worse than 76.97% of 990
companies
in the Oil & Gas industry
Industry Median: 0.565
vs CLB: 0.14
If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.
Core Laboratories Cash-to-Debt Related Terms
Core Laboratories Cash-to-Debt Historical Data
* Premium members only.
The historical data trend for Core Laboratories's Cash-to-Debt can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
For the Oil & Gas Equipment & Services subindustry, Core Laboratories's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Core Laboratories Cash-to-Debt vs Oil & Gas Industry
For the Oil & Gas industry and Energy sector, Core Laboratories's Cash-to-Debt distribution charts can be found below:
* The bar in red indicates where Core Laboratories's Cash-to-Debt falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Core Laboratories (CLB) has a Cash-to-Debt of 0.14 as of Jun. 2026. This is 100% above median its historical median of 0.07. Over the past decade, Core Laboratories' Cash-to-Debt has ranged from 0.03 to 0.18. According to the industry distribution chart, Core Laboratories ranks #762 out of 990 companies in the Oil & Gas industry, placing it in the top 77%.
Is Core Laboratories' Cash-to-Debt too high?
Core Laboratories' current Cash-to-Debt of 0.14 is 100% above median its 10-year median of 0.07. Over the past 10 years, this metric has ranged from a low of 0.03 to a high of 0.18. The Oil & Gas industry median Cash-to-Debt is 0.57. Core Laboratories' value of 0.14 is 75.2% below this industry median. Based on the distribution chart, Core Laboratories ranks #762 out of 990 companies in the Oil & Gas industry, which is in the bottom quartile relative to peers. Overall, Core Laboratories has a GF Score™ of 62/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Core Laboratories' Cash-to-Debt compare to OIS and EROK?
According to the Oil & Gas industry distribution chart, Core Laboratories ranks #762 out of 990 companies for Cash-to-Debt. This places Core Laboratories in the lower half of its industry. The industry median Cash-to-Debt is 0.57. Core Laboratories' value of 0.14 is 75.2% below this benchmark. Historically, Core Laboratories' own Cash-to-Debt has ranged from 0.03 to 0.18 over the past decade. While the company's 10-year median is 0.07 vs. the industry median of 0.57, Core Laboratories has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash-to-Debt for an Oil & Gas company?
The median Cash-to-Debt among Oil & Gas companies is 0.57, based on 990 companies in the industry. Companies in the top quartile (top 25%) have a Cash-to-Debt significantly above this median, while those in the bottom quartile fall well below. However, Cash-to-Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Core Laboratories's current Cash-to-Debt of 0.14 is 75.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash-to-Debt mean?
A high Cash-to-Debt can signal that a stock is expensive relative to its fundamentals. For the Oil & Gas industry, the median Cash-to-Debt is 0.57 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Core Laboratories's current Cash-to-Debt is 0.14, which is 100% above median its own 10-year median of 0.07. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Core Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Core Laboratories (CLB) is currently considered Significantly Undervalued. The stock's GF Value™ is $16.97, compared to a current price of $11.40 — trading 32.8% below its estimated fair value. The current Cash-to-Debt is 0.14, which is 100% above median its 10-year median of 0.07 and 75.2% below the Oil & Gas industry median of 0.57. Core Laboratories' overall GF Score™ is 62/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash-to-Debt calculated?
Cash-to-Debt is calculated from a company's financial statements. For Core Laboratories (CLB), the current Cash-to-Debt is 0.14 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Core Laboratories (CLB) Overvalued in 2026?
Based on GuruFocus' analysis, Core Laboratories stock appears to be undervalued.
The current stock price of $11.40 is trading 32.8% below its estimated GF Value™ of $16.97.
GuruFocus considers Core Laboratories to be Significantly Undervalued.
Key valuation signals for CLB:
Cash-to-Debt: 0.14 (100% above median its 10-year median of 0.07)
GF Value™: $16.97 vs. price of $11.40 (32.8% below fair value)
Industry Position: 75.2% below the Oil & Gas median (#762 of 990)
No single metric tells the full story. See the CLB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Core Laboratories Inc is a providers of proprietary and patented reservoir description and production enhancement services and products to the oil and gas industry, through client relationships. The company operates its business in two segments; Reservoir Description, and Production Enhancement. It provides data and analytics to aid well operators in determining optimal methods for recovering, processing, and refining hydrocarbons from a well. It also manufactures the associated lab equipment for its services. The company generates majority of its revenue from Reservoir Description segment.
62GF Score
Get the complete analysis for CLB
Cash-to-Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CLB has been successfully added to your 
